$ADGM SEC Filings

Filed On	Filing
26 Oct 2026	8-K: Submission of Matters to a Vote of Security Holders On October 23, 2026, Adagio Medical Holdings, Inc.’s (the “Company”) held a Special Meeting of Stockholders (the “Special Meeting”). The stockholders considered one proposal which is described in more detail in the Company’s definitive p...
13 Oct 2026	Form 4: Mirsaeedi-Farahani Keyvan, Director Acquired 12,770 shares (Other Transaction)
13 Oct 2026	Proxy statement: special meeting on October 23, 2026
01 Oct 2026	8-K: Unregistered Sales of Equity Securities As previously disclosed in Adagio Medical Holdings, Inc.’s (the “Company”) Current Report on Form 8-K filed on September 23, 2026, in connection with its process to explore strategic alternatives, the Company notified the holders (the “H...
01 Oct 2026	PRE 14A
23 Sep 2026	8-K: Cost Associated with Exit or Disposal Activities; Other Events Company Continues to Advance PMA Application for vCLAS Ventricular Ablation System While Board Evaluates Full Range of Strategic Options
14 Aug 2026	SCHEDULE 13G/A
14 Aug 2026	8-K: Notice of Delisting or Failure to Satisfy a Listing Rule
13 Aug 2026	8-K: Regulation FD Disclosure
12 Aug 2026	Form 4: Salmon Sean, Director Granted 30,000 Non-qualified stock option (right to buy)
12 Aug 2026	Form 4: Mirsaeedi-Farahani Keyvan, Director Granted 30,000 Non-qualified stock option (right to buy)
12 Aug 2026	Form 4: Cox James L, Director Granted 30,000 Non-qualified stock option (right to buy)
12 Aug 2026	Form 4: Gardiner Sandra A., Director Granted 30,000 Non-qualified stock option (right to buy)
12 Aug 2026	Form 4: Mishan Orly, Director Granted 100,000 Non-qualified stock option (right to buy)
12 Aug 2026	Form 4: Moran Timothy P., Director Granted 30,000 Non-qualified stock option (right to buy)
11 Aug 2026	10-Q
11 Aug 2026	8-K: Results of Operations and Financial Condition
28 Jul 2026	SCHEDULE 13G/A
13 Jul 2026	FORM 10-K/A
16 Jun 2026	8-K: Submission of Matters to a Vote of Security Holders

Comments